Phathom Pharmaceuticals, Inc. PHAT Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s earnings yield?
- Phathom Pharmaceuticals, Inc. (PHAT) reported earnings yield of -18% in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s earnings yield changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s earnings yield increased by 77.3% year-over-year, from -79.2% to -18%.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s earnings yield?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s earnings yield has grown at a 8.8% compound annual growth rate (CAGR), from -12.3% to -18.7%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.